XtalPi
Lipeng has a diverse background in mathematics and physics, including particle physics, fluid dynamics, biophysics, and complex networks. As XtalPi’s co-founder, he is currently leading the company’s Beijing team, which is focusing on the application of AI technologies in the development of new therapeutics. By integrating big data from biology and chemistry with deep learning algorithms, XtalPi aims to provide solutions that can e actively accelerate drug discovery. The team is also seeking in-depth collaboration projects with researchers to explore the potential of AI in fundamental research areas such as biology and chemistry.
Lipeng received his double B.S. degree in physics and mathematics from Peking University and his Ph.D. in physics from the University of Chicago. He was an SUTD- MIT graduate fellow at MIT when he co-founded XtalPi.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.